Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.

Bernal-Lopez MR, Santamaría-Fernandez S, Lopez-Carmona D, Tinahones FJ, Mancera-Romero J, Peña-Jimenez D, Jansen-Chaparro S, Baca-Osorio AJ, Cuesta-Muñoz AL, Serrano-Rios M, Gomez-Huelgas R.

Diabet Med. 2011 Nov;28(11):1319-22. doi: 10.1111/j.1464-5491.2011.03317.x. Epub 2011 Apr 16.

PMID:
21966956
2.

Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population.

Costa B, Barrio F, Cabré JJ, Piñol JL, Cos FX, Solé C, Bolibar B, Castell C, Lindström J, Barengo N, Tuomilehto J; DE-PLAN-CAT Research Group..

Diabet Med. 2011 Oct;28(10):1234-7. doi: 10.1111/j.1464-5491.2011.03304.x.

PMID:
21429007
3.

A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.

Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S, Ba H, Valensi P.

Diabetes Metab. 2010 Sep;36(4):312-8. doi: 10.1016/j.diabet.2010.02.004.

PMID:
20627649
4.

Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.

Soulimane S, Simon D, Shaw JE, Zimmet PZ, Vol S, Vistisen D, Magliano DJ, Borch-Johnsen K, Balkau B.

Diabet Med. 2011 Nov;28(11):1311-8. doi: 10.1111/j.1464-5491.2011.03403.x.

PMID:
21824186
5.

Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).

Heianza Y, Arase Y, Fujihara K, Tsuji H, Saito K, Hsieh SD, Kodama S, Shimano H, Yamada N, Hara S, Sone H.

Diabet Med. 2012 Sep;29(9):e279-85. doi: 10.1111/j.1464-5491.2012.03686.x.

PMID:
22510023
6.

Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.

Mukai N, Doi Y, Ninomiya T, Hata J, Hirakawa Y, Fukuhara M, Iwase M, Kiyohara Y.

Diabet Med. 2012 Jan;29(1):99-106. doi: 10.1111/j.1464-5491.2011.03378.x.

PMID:
21726278
7.

Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.

Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H.

Eur J Epidemiol. 2011 Oct;26(10):779-87. doi: 10.1007/s10654-011-9619-9. Epub 2011 Sep 27.

PMID:
21947790
8.

HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).

Valdés S, Botas P, Delgado E, Alvarez F, Díaz-Cadórniga F.

Diabetes Metab. 2011 Feb;37(1):27-32. doi: 10.1016/j.diabet.2010.07.002. Epub 2010 Oct 8.

PMID:
20934897
9.

Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.

Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A.

Diabet Med. 2012 Jan;29(1):94-8. doi: 10.1111/j.1464-5491.2011.03392.x.

PMID:
21790773
10.

Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).

Liberopoulos EN, Florentin M, Kei A, Mountzouri E, Agouridis A, Elisaf MS.

J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):543-8. doi: 10.1111/j.1751-7176.2010.00318.x.

11.

HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.

Bhowmik B, Diep LM, Munir SB, Rahman M, Wright E, Mahmood S, Afsana F, Ahmed T, Khan AK, Hussain A.

Diabet Med. 2013 Mar;30(3):e70-7. doi: 10.1111/dme.12088. Erratum in: Diabet Med. 2016 Feb;33(2):271.

PMID:
23199158
12.
13.

Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.

Hutchinson MS, Joakimsen RM, Njølstad I, Schirmer H, Figenschau Y, Jorde R.

J Endocrinol Invest. 2012 Oct;35(9):835-40. doi: 10.3275/8191. Epub 2011 Dec 16.

PMID:
22186659
14.

HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.

Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, Tsuji H, Kodama S, Hsieh SD, Mori Y, Shimano H, Yamada N, Kosaka K, Sone H.

Lancet. 2011 Jul 9;378(9786):147-55. doi: 10.1016/S0140-6736(11)60472-8. Epub 2011 Jun 24.

PMID:
21705064
15.

Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

Inoue K, Matsumoto M, Akimoto K.

Diabet Med. 2008 Oct;25(10):1157-63. doi: 10.1111/j.1464-5491.2008.02572.x.

PMID:
19046193
16.

Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.

Martin DD, Shephard MD, Freeman H, Bulsara MK, Jones TW, Davis EA, Maguire GP.

Med J Aust. 2005 May 16;182(10):524-7. Erratum in: Med J Aust. 2005 Jun 20;182(12):656. Bulsara, Max K [added].

PMID:
15896181
17.

Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.

Schöttker B, Müller H, Rothenbacher D, Brenner H.

Diabetologia. 2013 Jan;56(1):92-100. doi: 10.1007/s00125-012-2707-x. Epub 2012 Sep 19.

PMID:
22986731
18.

Use of HbA(1C) testing to diagnose pre-diabetes in high risk African American children: a comparison with fasting glucose and HOMA-IR.

Sharma S, Fleming SE.

Diabetes Metab Syndr. 2012 Jul-Sep;6(3):157-62. doi: 10.1016/j.dsx.2012.09.004. Epub 2012 Oct 30.

PMID:
23158980
19.

High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).

Heianza Y, Arase Y, Fujihara K, Tsuji H, Saito K, Hsieh SD, Kodama S, Shimano H, Yamada N, Hara S, Sone H.

Diabet Med. 2012 Oct;29(10):1285-90. doi: 10.1111/j.1464-5491.2012.03667.x.

PMID:
22486679
20.

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group..

Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.

PMID:
19515182

Supplemental Content

Support Center